

PAH Pathways offers a wealth of resources including one-on-one support from PAH Pathways counselors in your area.
Learn more »
PAH Pathways counselors understand that you may have concerns when it comes to paying for pulmonary arterial hypertension (PAH) therapy. That's why they offer comprehensive and practical reimbursement information.
PAH Pathways counselors help simplify the process by:
Tips for patients with private insurance
There are a number of financial assistance programssponsored both by PAH Pathways and other sourcesthat may help eligible Ventavis patients pay for their therapy:
*Caring Voice Coalition is a nonprofit, independent third-party organization.
†Ineligible patients: Any patients whose prescriptions are paid for by the government, Medicare, Medicaid, VA/DOD (Tricare), or Indian Health Service, patients in Massachusetts and Puerto Rico, or where prohibited by law.
Ventavis is indicated for the treatment of pulmonary arterial hypertension (WHO Group I) in patients with NYHA Class III or IV symptoms.
Important safety information about Ventavis
Because it lowers your blood pressure, Ventavis may cause dizziness, lightheadedness, and fainting. With Ventavis, the most common side effects are reddening of the face caused by dilation of blood vessels (flushing), increased cough, low blood pressure (hypotension), headaches, nausea, spasm of the jaw muscles that causes trouble opening your mouth, and fainting (syncope); other serious adverse events reported with the use of Ventavis include congestive heart failure, chest pain, supraventricular tachycardia, dyspnea, peripheral edema, and kidney failure. Before you start taking Ventavis, talk to your doctor to make sure you understand the side effects you might get.
Please see accompanying full Prescribing Information.
Tracleer
Please see accompanying full Prescribing Information, including BOXED WARNING and Medication Guide for Tracleer.